Ophthalmology

Latest News

european medicines agency and biosimilars | Image credit: Brenda Blossom - stock.adobe.com
CHMP Pushes 3 Biosimilars Forward, Spelling Hope for Ophthalmology, Supportive Care Markets

February 6th 2025

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended 3 biosimilars and new indications for reference biologics, moving them closer to final European approval and expanding patient access.

Eye disease. | Image Credit: Orawan - stock.adobe.com
Interchangeable Aflibercept Biosimilar, Enzeevu, Comparable With Eylea for nAMD

February 6th 2025

There are already several biosimilars approved within these specialty areas, with more on the horizon. | Image credit: lexiconimages - stock.adobe.com
Integrating Biosimilars Into Retina and Neurology Practices Requires Careful Planning

January 29th 2025

eye on pharma banner
Eye on Pharma: Teva, Formycon, Celltrion Biosimilar Updates in Global Markets

January 26th 2025

japan flag over tokyo | Image credit: Savvapanf Photo © - stock.adobe.com
Cost-Benefits, Efficacy of Biosimilar Ranibizumab vs Aflibercept for nAMD in Japan

January 22nd 2025

Video Interviews
Podcasts
CFB podcast banner
"SEEING EYE TO EYE:  Exploring Different Perspectives on Ophthalmology Biosimilars SEEING EYE TO EYE:  Exploring Different Perspectives on Ophthalmology Biosimilars" with the CfB logo and an image of an eye
CfB podcast banner
CfB podcast banner
CfB podcast banner

More News

© 2025 MJH Life Sciences

All rights reserved.